Essais liés3clinical trials
VilleFranklinlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06701526

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
Eptinezumab Migraine Phase 4 NCT06701526 A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications COMPLETED
Botulinum toxin type A Migraine Phase 3 NCT06047457 E-BEOND — A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults ACTIVE_NOT_RECRUITING
Botulinum toxin type A Migraine Phase 3 NCT06047444 C-BEOND — A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults ACTIVE_NOT_RECRUITING